Microwave zaps prostate tumors without major surgery
NCT ID NCT03023345
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested a new way to treat low-risk prostate cancer using a microwave probe inserted through the rectum. The goal was to see if it could safely destroy the main tumor while protecting nearby tissues. Eleven patients were treated, and the researchers checked for complete tumor death on MRI scans and monitored side effects like sexual function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- microwave ablation device (TATO system)
- What this could lead to
- If successful, this could offer a less invasive treatment option for low-risk prostate cancer, potentially reducing side effects like erectile dysfunction.
- What could go wrong
- This was a very small early feasibility study (11 patients) with no control group, so results may not apply broadly. Long-term cancer control and safety are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOW RISK PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Assistance Publique - Hôpitaux de Paris
Paris, Paris, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.